Dr. Christine M. Dunham's lab focuses on understanding how certain bacteria, especially Pseudomonas aeruginosa, resist antibiotics through specialized mechanisms. They study a particular group of proteins called RND efflux pumps, which help these bacteria expel antibiotics and survive in challenging environments. The research aims to uncover the genetic and molecular processes behind this resistance, paving the way for better treatments against difficult bacterial infections.

Dr. Kyle Biegasiewicz's research lab focuses on developing innovative enzymes that can improve chemical reactions important for drug manufacturing. By studying haloperoxidase enzymes, the lab aims to create more environmentally friendly and selective methods for introducing halogens into organic compounds. This research could lead to better pharmaceuticals with enhanced therapeutic properties.

Dr. Khalid S. Salaita's lab at Emory University focuses on understanding and innovating diagnostic techniques related to blood coagulation and platelet activity. The research aims to develop new technologies to detect heparin-induced thrombocytopenia (HIT) more quickly and accurately, while also exploring the role of mechanical forces in cellular processes. The lab works at the intersection of chemistry and biology to create tools that can revolutionize how we diagnose and manage various blood-related medical conditions.